We describe an unusual case in which a 35-year-old man presented with skull base mucormycosis with osteomyelitis secondary to squamo us cell carcinoma of the temporal bone. We also review the literature on the clinical characteristics, diagnosis, and treatment of mucormycosis.
Introduction
Skull base osteomyelitis is a compl ication of fungal infection that may be seen in immunocompromised patie nts. The most common causative pathogen s are Asp ergillus , Candida , and Cryptococcus spp . We enco untered an unusual case of skull base osteomyelitis seco ndary to mucormycosis. The fungal infection was diag nosed only after the patient had been diagnosed with squamous cell carci noma of the temporal bone.
Case report
A35-year-old man initially presented to our outpatient clinic with a IO-year history ofleft ear discharge that would subside with medi cation. Six months earlier, he had developed left-sided facial para lysis with associa ted left-sided facia l pain and severe headache. He underwent a left mastoid exploration under general anesthesia. Intrao perative ly, a large cho lesteatoma sac was fou nd filling the antrum and extending to the mesotympanic and ep itympan ic areas. Also, the vertical part of the fac ial nerve had been exposed by the disease process.
Postoperatively, the patient continued to com plain of severe faci al and periauri cular pain. The facial paralysi s dimini shed initially, but it returned 3 month s after surgery. It was with these complaints that the patient presented to us and was subsequently admitted.
In addition to the aforeme ntio ned symptoms, the patient repo rted the onset of vertigo and a blood -stained aura l discharge. He had also experienced one episode of double vision, whic h resolved spontaneously.
Upon further questioning, the patient related no history of tuberculosis, dia betes, or any co nditio n that wou ld suggest an immun ocompromised state. Our physical examination revealed the presence oftorticollis and neck rigidity associated with grade II trismus. The patient reported fullness in the area of the left sternocleidomastoid muscle and a soft, tender swelling in the left postauric ular area . His left ear was discharging purulent, blood -stained fluid, and gran ulations were see n protruding through the meatoplasty. In addition to the left facia l nerve palsy, a defici t was noted in the ipsilateral VIIIth nerve. Findi ngs on the remainder of the neurologic exa mination were normal.
Rout ine laboratory tests revealed an eleva ted alkaline phosp hatase level (168 IU; normal: <90) and elevated erythrocy te sedimentation rate (36 mm for the first hour ; norma l: 0 to 20); the blood glucose level and the results of kidney function tests were normal, and the enzy me-linked immunosorbent assay for hum an imm unodeficiency virus was negative. An ear swab culture yielded Staphylococcus aureus, which was sensitive to lincomycin and vancomyci n. A biopsy of the granulatio n tissue in the left ear was sent for histopathology and microbi olog y. Histopathologic analysis revealed the presence of a moderatel y differentiated squamous cell carcinoma. Microbi ologic examination on a 10% potassium hydrox ide mount identified epitheli al cells invaded by broad aseptate hyph ae. Hematoxylin and eosin staining of tissue identified broad, ribbon -like aseptate hyphae (figure I). The granulation tissue biopsy was positive on periodic acid-Schiff staining. Incubation in Sabo uraud 's dextrose agar (at 25°C) and brain-heart infusion agar (at 37°C) for 6 days yielded a grayi sh growth with aerial mycelia. The lactophenol cotton blue moun t from the grow th revealed Mucor spp. A culture for Mycobacterium tuberculosis was sterile after 10 weeks of incubatio n. Co ntrast-enhanced comp uted tom ograph y (CT) of the temp oral bone (3-mm serial cuts) demonstra ted (I) heterogenously enhancing den sities with loculated co llectio ns in the left middle ear and mastoid cavi ties, (2) gross destruc tion of the mastoid por tio n of the left tem poral bone, left occipital bo ne, and adjacent basis phenoid bo ne, and (3) destru ction of the carotid ca nal, ju gular foramen, and styloid process (figure 2). Erosion of the left lateral mass of the atlas (C I ) was see n with extradu ral and subdura l extension into the epidura l spinal canal.
ENT-Ear
On the basis of these findin gs, we made a diag nosis of sk ull base osteomyelitis and muco rmy cosis secondar y to squamous ce ll carc inoma of the tem poral bone.Th e patient was treated with intravenou s ampho tericin B at a dose of 0.2 mg/kg/day and with IV ceftazidime , amox icillin/c lavulanate, and metronidazole. He was also administere d full-dose radiotherapy for the malignancy.
Th e patient returned to the hospital's outpatien t unit for 3 weeks follow ing treatment but was subse quently lost to follow-up.
Discussion
Most invasive fungal infec tions occ ur in patien ts with prolonged neutropenia, in critica lly ill patients in intensive care, in patients undergoing che motherapy for solid tumors, in patients with acq uired imm unodeficiency syndrome, and in patie nts who have received an organ tran splant. I A secondary infectio n by an opportunistic fungus in an already -im munocompro mised patient is not easy to diagnose or treat, and the prognosis for patients with this life-thr eatening complica tio n is poor. Improvement s in the management of bacterial infec tio ns in cancer patie nts have res ulted in a dec rease in the incidence of invasive fungal infections in this gro up.
Proven invasive fungal infec tio ns are divided into three categories: deep-tissue infections.fungemias, and endem-Volume 85, Number 12
Figure 2. A: Axia l contras t-enhanced CT of the tempora l bone shows the destruction ofthe left mastoid area and the erosion of the adjacent atlas. Band C: Coronal views show the evidence of skull base osteomyelitis and erosion of the basisp henoid bone.
ic funga l injections. The diag nosis requires a pos itive blood culture , histopathologic analysis, or cytopathologic evidence of fungus and damage to tiss ue.
Mu corm ycosis is ca used by fungi of the order of Mucora les and Entom ophth orales; among the genera are Absidia, Mucor, and Rhizopus. Mu corm ycosis includes diseases cau sed by all members of the class Zygomy-existing squam ous cell carcinoma. We must emph asize that a search for a primary malignanc y in the temp oral bone should be ac tively undert aken in similar cases of skull base osteomyelitis with muc orm ycosis if all other cau ses of immunocompromise have been ruled out.
Recognit ion of mucormycosis, a potentially fatal infection, requires a high inde x of suspicion and knowledge of its atypical clini cal and radiolo gic features. cete s, henc e it is also know n as zygo mycos is. Th e fun gi are generally saprophytic and rarel y cause disease in an immunoc ompetent host. Histologic differenti ati on of Mu cor and Aspe rgillus fungi is based on the app earanc e of the hyph ae; Mucor spp. feature ase ptate, ribbon-like , hapha zardl y branching hyphae, while Aspe rgillus spp. are characteri zed by septate hyph ae with uniform diam eters and dichotomous branching."
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Mucormyco sis is the third most common opp ortunistic fungal infection in immunocompromised and diabetic patient s. In these patient s, the infecti on is acute and rapidly fatal, even when it is diagnosed early and treated pro mptl y. The infection has no predil ection for either sex or for any specific age group , race, or geographic area. It may present in a rhin ocereb ral, pulmonary, abdominal, pelvic, or gastrointestinal site; it may even affect the skin before dissemin ating. Regional involvement determines morbidity and mortality. For exa mple, the rhinoc erebral form is associated with an 85% mortalit y; the overall mortal ity is 50%.3Th e primary determinant of surviva l is the length of time bet ween the onset of infection and its treatment. In most cases, by the time mucormycosis is diagno sed , fungal invasion is so wides pread and diffuse that ther apy is unable to halt the progress of the disease.'
Treatment invol ves a combination of surgical (debridement ) and medic al modalities. Amphoteri cin B exe rts broad-spectrum coverage and rem ains the drug of cho ice for life-threatening invasive fung al infections.' Since the 1990 s, the number of ava ilable oral and parenteral antifunga l agents has increa sed significantly. The use of phosph olip id carri ers for amphotericin B or cyclo dex trine carriers for the triazoles (e.g., itraconazo le and fluconazole) has impro ved safe ty profiles and/or pharmacokinetic s. Thre e investigational agent s under study are vorico nazo le, posaconazole, and ravucon azole. l" Other new antifunga ls (e.g., echinoca ndins) that have a novel mechani sm of action have been introduced into clinical practice, but studies have yet to determine their exac t role in the management of different myco ses.
The occurrence of conc omit ant rhin ocerebral mucormycosis and skull base osteomyelitis is not an altoge ther unusual phenomenon today, considering the incre asing numb er of immunocompromised patients." Wh at was unusual in our case is that the infection was seco ndary to a squamous cell carc inoma of the temp oral bone. Mo st cases of muc orm ycosis with skull base osteom yelitis that have been reported thus far have been sinonasa l, orbital, or deep facial soft-tissue infec tions. Most cases of skull base osteo myelitis seco ndary to ear infections result from malignant otit is externa and are pseud omonal or ca ndida l in origin.' Th erefore , the unu sual pre sentati on in the case described herein posed a bit of a diagnostic puzzle. The per sistent pain and ear discharge, coupl ed with the positi ve culture report for the fun gus, is what clinched the diagnosis. Our pat ient was immunocomp romi sed by his
